Pharmaceutical Industry Articles & Reports - Page 10

Examine AI in pharma HEOR and real-world evidence. This report details how machine learning and RWD advance health economic modeling and regulatory decisions.

Review the FDA full approval of Tecartus for relapsed mantle cell lymphoma. This analysis covers ZUMA-2 Cohort 3 efficacy data, CAR-T safety, and clinical use.

Review the Veeva Vault 26R2 release preview. Learn about mid-2026 platform enhancements, including document viewer upgrades, QMS, RIM, and safety workflows.

Analyze the 2026 biotech capital outlook, detailing Blackstone's record $6.3B Life Sciences Fund VI, VC funding trends, biopharma M&A, and market recovery.

Review the 2026 pharma AI vendor landscape. This analysis details 150+ companies using machine learning for drug discovery, clinical trials, and manufacturing.

Examine the FDA approval of Otarmeni, the first gene therapy for OTOF-related congenital hearing loss, and its expedited National Priority Voucher review.

Analyze AcuityMD's $80M Series C funding and the role of AcuityAI. Learn how agentic AI optimizes MedTech commercial operations, sales, and market access.

A 2026 comparison guide of open-source LIMS platforms for life science labs. Learn about system architectures, customizability, and compliance trade-offs.

Analyze the $1B Merck and Google Cloud partnership. This report explains how agentic AI and Gemini Enterprise apply to pharmaceutical R&D and data workflows.

Understand why large language models (LLMs) improve performance when given high-stakes or emotional prompts, and explore research on the EmotionPrompt effect.

Analyze LLM position bias, including primacy and recency effects in transformer models. Learn how prompt structure impacts attention and generation accuracy.

Examine the impact of Novartis CEO Vas Narasimhan joining Anthropic's board. This report analyzes pharma AI governance, healthcare regulations, and drug R&D.

Review this 2026 vendor comparison of clinical trial payment software. Analyze automated site payment and participant stipend management system capabilities.

Analyze Q1 2026 biopharma M&A trends, including 19 billion-dollar deals. Learn how patent cliffs and AI valuation drivers impact pharmaceutical acquisitions.

Analyze the role of multi-agent AI and co-scientist architectures, including withZeta.ai, in accelerating rare cancer drug discovery and modern oncology R&D.

Review AI molecule prioritization methods and computational triage tools used in drug discovery pipelines to filter generative AI candidates via ADMET and QSAR.

Read a comprehensive analysis of Veeva's Ostro acquisition. Learn how conversational AI integrates with Vault CRM for MLR-compliant HCP and patient engagement.

Review essential features of Anatomic Pathology LIMS, including digital pathology integration, compliance, and workflows for histopathology and cytology.

Examine how Isomorphic Labs uses AlphaFold AI to advance its first computationally designed oncology and immunology therapeutics into clinical trials.

Explore the updated EU GMP Annex 1 guidelines for sterile manufacturing. Learn how to implement a risk-based Contamination Control Strategy (CCS) for compliance

Understand how AI automates regulatory medical writing for CTD Module 2 summaries in IND and NDA submissions, including efficiency gains and compliance risks.

Analyze the AI-enabled precision proteomics market through the Alamar Biosciences $191M IPO, NULISA technology, and the future of protein biomarker detection.

Learn about CDISC SEND datasets for FDA nonclinical submissions. This guide explains SDTM framework alignment, SENDIG rules, and regulatory compliance timelines

Explore Kailera Therapeutics' $625M IPO and GLP-1 obesity pipeline. This analysis covers clinical data, dual agonists, and the 2026 biotech market reopening.